Randomized phase II trial (RENO): Efficacy results of oral vinorelbine or etoposide combined with cisplatin in chemo-radiotherapy treatment of locally advanced NSCLC (LA-NSCLC)—SLCG 10/02

Autor:	Pilar Diz, Mariano Provencio, Ramon Garcia-Gomez, Angel Artal-Cortes, Ramon De Las Penas, Pilar Mut Sanchis, José Miguel Jurado, José Gómez-Codina, Natividad Martínez-Banaclocha, Maria Francisca Vazquez, Dolores Isla, Miguel Angel Muñoz Quintana, Raquel Marse Fabregat, Angeles Sala, Amelia Insa, Teresa Moran, Ana Laura Ortega, Nuria Viñolas, Bartomeu Massuti, Vanesa Gutierrez Calderon
Rok vydání:	2016
Předmět:	0301 basic medicine Cisplatin Oncology Cancer Research medicine.medical_specialty Chemo-radiotherapy business.industry Locally advanced Vinorelbine Surgery 03 medical and health sciences 030104 developmental biology 0302 clinical medicine 030220 oncology & carcinogenesis Internal medicine medicine business Etoposide medicine.drug
Zdroj:	Journal of Clinical Oncology. 34:8538-8538
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2016.34.15_suppl.8538
Popis:	8538Background: This study aims to compare efficacy and safety of two widely used combinations of cisplatin (P) in this setting: as etoposide (E) and vinorelbine. This last, in its oral formulation...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::38e557c29571b0c8421bd316428a24ba https://doi.org/10.1200/jco.2016.34.15_suppl.8538 Zobrazit plný text záznamu